Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Melanoma 10Neoplasm Metastasis 7Leukemia, Myeloid, Acute 7Carcinoma, Renal Cell 7Myelodysplastic Syndromes 5Leukemia, Lymphocytic, Chronic, B-Cell 5Hematologic Neoplasms 5Prostatic Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Pancreatic Neoplasms 4Lymphoma, Non-Hodgkin 4Triple Negative Breast Neoplasms 3Ovarian Neoplasms 3Myeloproliferative Disorders 3Multiple Myeloma 3Lung Neoplasms 3Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Hodgkin Disease 3Clear-cell metastatic renal cell carcinoma 3Carcinoma, Non-Small-Cell Lung 3Burkitt Lymphoma 3Breast Neoplasms 3Uveal Melanoma 2Uterine Cervical Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Neuroblastoma 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2

Interventions

Fluorouracil 71pembrolizumab 63Bevacizumab 60Oxaliplatin 59Cetuximab 59Leucovorin 56Irinotecan 55Capecitabine 31Nivolumab 23Cisplatin 19Gemcitabine 18IFL protocol 17Folfox protocol 17Cyclophosphamide 16Carboplatin 16atezolizumab 14Specimen Handling 14Paclitaxel 14Magnetic Resonance Spectroscopy 14Biopsy 14trifluridine tipiracil drug combination 12Pemetrexed 11spartalizumab 9regorafenib 9fludarabine 9Panitumumab 9130-nm albumin-bound paclitaxel 9trametinib 8durvalumab 8dehydroftorafur 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Colorectal Neoplasms × CTLA-4 Antigen × Clear all
NCT04362839 2026-01-28

Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer

City of Hope Medical Center

Phase 1 Completed
39 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT03373188 2024-03-20

VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer

Emory University

Phase 1 Completed
10 enrolled
Gastrointestinal

Pancreatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡